To investigate the diagnostic value of core-needle biopsy (CNB) guided by contrast-enhanced ultrasound (CEUS) in cervical tuberculous lymphadenitis (CTL).
METHODS:
178 patients with pathological confirmation of CTL were retrospectively enrolled. All of them had undergone CNB prior to the final surgery. According to the different ways of puncture guidance, they were divided into two groups: conventional ultrasound (US) group (n = 81) and CEUS group (n = 97). The comparison of diagnostic efficacy between two groups was compared and analyzed.
RESULTS:
Among the 178 patients, 146 were directly diagnosed as CTL by CNB, including 59 patients in CEUS group and 87 patients in US group. The diagnostic accuracy were 89.7% (87/97) and 72.8% (59/81), respectively (P < 0.01). For subgroup analyses, differences among diagnostic efficacy ascribed to the different guiding methods were significant in medium size group (>2.0 cm and ≤3.0 cm) and large size group (>3.0 cm), 91.7% for CEUS group vs. 69.0% for US group (P < 0.05) and 84.4% for CEUS group vs. 57.7% for US group (P < 0.05), respectively.
CONCLUSIONS:
In the diagnosis of CTL, compared with the US-guided CNB, CEUS-guided CNB have certain advantages, especially for larger lymph nodes.
AltuwairgiO, BaharoonS, AlkababY, AlsafiE, AlmoweqelM, HALJ. Ultrasound-guided core biopsy in the diagnostic work-up of tuberculous lymphadenitis in Saudi Arabia, refining the diagnostic approach. Case series and review of literature. Journal of Infection and Public Health. 2014;7(5):371–6.
4.
BezabihM, MariamDW, SelassieSG. Fine needle aspiration cytology of suspected tuberculous lymphadenitis. Cytopathology: Official Journal of the British Society for Clinical Cytology. 2002;13(5):284–90.
5.
el HagIA, ChiedoziLC, al ReyeesFA, KollurSM. Fine needle aspiration cytology of head and neck masses. Seven years’ experience in a secondary care hospital. Acta Cytologica. 2003;47(3):387–92.
6.
WrightCA, HesselingAC, BamfordC, BurgessSM, WarrenR, MaraisBJ. Fine-needle aspiration biopsy: a first-line diagnostic procedure in paediatric tuberculosis suspects with peripheral lymphadenopathy?The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease. 2009;13(11):1373–9.
7.
KimBM, KimEK, KimMJ, YangWI, ParkCS, ParkSI. Sonographically guided core needle biopsy of cervical lymphadenopathy in patients without known malignancy. Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine. 2007;26(5):585–91.
8.
ScreatonNJ, BermanLH, GrantJW. Head and neck lymphadenopathy: evaluation with US-guided cutting-needle biopsy. Radiology. 2002;224(1):75–81.
9.
HowlettDC, MenezesL, BellDJ, AhmedI, WitcherT, BhattiN, et al.Ultrasound-guided core biopsy for the diagnosis of lumps in the neck: results in 82 patients. The British Journal of Oral & Maxillofacial Surgery. 2006;44(1):34–7.
10.
SolbiatiL, IeraceT, TonoliniM, CovaL. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. European Journal of Radiology. 2004;51(Suppl):S19–23.
11.
DiederichS, PadgeB, VossasU, HakeR, EidtS. Application of a single needle type for all image-guided biopsies: results of 100 consecutive core biopsies in various organs using a novel tri-axial, end-cut needle. Cancer imaging: the official publication of the International Cancer Imaging Society. 2006;6:43–50.
12.
LencioniR, CaramellaD, BartolozziC. Percutaneous biopsy of liver tumors with color Doppler US guidance. Abdominal Imaging. 1995;20(3):206–8.
13.
BirthM, IblherP, HildebrandP, NoldeJ, BruchHP. [Ultrasound-guided interventions using magnetic field navigation. First experiences with Ultra-Guide 2000 under operative conditions]. Ultraschall in der Medizin (Stuttgart, Germany : 1980). 2003;24(2):90–5.
14.
BangN, Bachmann NielsenM, VejborgI, Mellon MogensenA. Clinical report: contrast enhancement of tumor perfusion as a guidance for biopsy. European Journal of Ultrasound: Official Journal of the European Federation of Societies for Ultrasound in Medicine and Biology. 2000;12(2):159–61.
15.
SkjoldbyeB, PedersenMH, StruckmannJ, BurcharthF, LarsenT. Improved detection and biopsy of solid liver lesions using pulse-inversion ultrasound scanning and contrast agent infusion. Ultrasound in Medicine & Biology. 2002;28(4):439–44.
16.
SchlottmannK, KleblF, ZorgerN, FeuerbachS, SchölmerichJ. Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. Zeitschrift fur Gastroenterologie. 2004;42(4):303–10.
17.
ParedesJM, RipollésT, CortésX, MorenoN, MartínezMJ, Bustamante-BalénM, et al.Contrast-enhanced ultrasonography: usefulness in the assessment of postoperative recurrence of Crohn’s disease. Journal of Crohn’s & Colitis. 2013;7(3):192–201.
18.
FuT, DingH, XuC, ZhuY, XueL, LinF. Imaging findings of fibrolamellar hepatocellular carcinomas on ultrasonography: A comparison with conventional hepatocellular carcinomas. Clinical hemorheology and microcirculation. 2020 Sep 7. doi: 10.3233/CH-200896
19.
ChenK, DongY, ZhangW, HanH, MaoF, ZhangQ, et al. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications. Clinical Hemorheology and Microcirculation. 2020 Jul 16. doi: 10.3233/CH-200899
20.
WilsonSR, BurnsPN. Microbubble-enhanced US in body imaging: what role?Radiology. 2010;257(1):24–39.
21.
BadeaR, SocaciuM, CiobanuL, HagiuC, GoleaA. Contrast-enhanced ultrasonography (CEUS) for the evaluation of the inflammation of the digestive tract wall. Journal of Gastrointestinal and Liver Diseases: JGLD. 2010;19(4):439–44.
22.
JungEM, StroszczynskiC, JungF. Contrast enhanced ultrasonography (CEUS) to detect abdominal microcirculatory disorders in severe cases of COVID-19 infection: First experience. Clinical Hemorheology and Microcirculation. 2020;74(4):353–61.
23.
EnarsonDA, AshleyMJ, GrzybowskiS, OstapkowiczE, DorkenE. Non-respiratory tuberculosis in Canada. Epidemiologic and bacteriologic features. American Journal of Epidemiology. 1980;112(3):341–51.
24.
MohapatraPR, JanmejaAK. Tuberculous lymphadenitis. The Journal of the Association of Physicians of India. 2009;57:585–90.
25.
PekerA, BalciP, Basara AkinI, ÖzgülHA. Shear-Wave Elastography-Guided Core Needle Biopsy for the Determination of Breast Cancer Molecular Subtype. 2020.
26.
DangoreSB, DegwekarSS, BhowateRR. Evaluation of the efficacy of colour Doppler ultrasound in diagnosis of cervical lymphadenopathy. Dento Maxillo Facial Radiology. 2008;37(4):205–12.
27.
SidhuPS, CantisaniV, DietrichCF, GiljaOH, SaftoiuA, BartelsE, et al.The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall in der Medizin (Stuttgart, Germany : 1980). 2018;39(2):e2–e44.
28.
FengH, Ru-haiZ, XiL, Yong-hongX, Jian-huaZ, Xiao-qingP, et al.Evaluation of basic and contrast-enhanced ultrasound in the diagnosis of enlarged superficial cervical lymph nodes. Chinese Journal of Ultrasonography. 2010;19(3):234–7.
29.
FlintD, MahadevanM, BarberC, GraysonD, SmallR. Cervical lymphadenitis due to non-tuberculous mycobacteria: surgical treatment and review. International Journal of Pediatric Otorhinolaryngology. 2000;53(3):187–94.
30.
ArtensteinAW, KimJH, WilliamsWJ, ChungRC. Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 1995;20(4):876–82.
31.
McCartenKM, NadelHR. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma. 2019;49(11):1545–64.
32.
WendlCM, MüllerS, MeierJ, FellnerC, EiglspergerJ, GosauM, et al.High resolution contrast-enhanced ultrasound and 3-tesla dynamic contrast-enhanced magnetic resonance imaging for the preoperative characterization of cervical lymph nodes: First results. Clinical Hemorheology and Microcirculation. 2012;52(2-4):153–66.
33.
El-GalalyTC, VillaD, GormsenLC, BaechJ, LoA, CheahCY. FDG-PET/CT in the management of lymphomas: current status and future directions. Journal of Internal Medicine. 2018;284(4):358–76.
34.
SparchezZ, RaduP, ZahariaT, KacsoG, GrigorescuI, BotisG, et al.Usefulness of contrast enhanced ultrasound guidance in percutaneous biopsies of liver tumors. Journal of Gastrointestinal and Liver Diseases: JGLD. 2011;20(2):191–6.
35.
YoonSH, LeeKH, KimSY, KimYH, KimJH, LeeSH, et al.Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound. European Radiology. 2010;20(8):2047–56.
36.
SporeaI, BadeaR, PopescuA, SpârchezZ, SirliRL, DănilăM, et al.Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice. Ultraschall in der Medizin (Stuttgart, Germany : 1980). 2014;35(3):259–66.
37.
ChanAK, HegartyC, KlassD, YoshidaE, ChungS, LiuDM, et al.The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study. Canadian Association of Radiologists Journal=Journal l’Association Canadienne Des Radiologistes. 2015;66(2):171–8.
